Your session is about to expire
← Back to Search
EHR-Based Interventions for Breast and Ovarian Cancer Genetic Testing
N/A
Waitlist Available
Research Sponsored by Abramson Cancer Center of the University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Unaffected individuals reporting a family history of breast cancer <50 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within one month of receiving referral
Awards & highlights
Study Summary
This trial aims to increase genetic testing and counseling to help save lives through life-saving screenings.
Who is the study for?
This trial is for people with a family history of breast or ovarian cancer, especially if diagnosed before age 50, and those with specific types of these cancers diagnosed over two years ago. It's not open to anyone who has already had genetic counseling or testing.Check my eligibility
What is being tested?
The study tests different ways to communicate through electronic health records (EHR) to see which method increases the rate at which people get genetic testing for breast and ovarian cancer predisposition.See study design
What are the potential side effects?
Since this trial involves communication interventions rather than medications, there are no direct physical side effects. However, learning about genetic risks can have emotional or psychological impacts.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My family has a history of breast cancer before age 50.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within one month of receiving mpm
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within one month of receiving mpm
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Genetic Counseling Appointments Completed Following MPM Delivery
Number of Genetic Counseling Appointments Completed Following Provider Nudge
Secondary outcome measures
Open Rate of MPM
Response Rate of Way To Health text
Other outcome measures
Number of Signed Referrals
Trial Design
1Treatment groups
Experimental Treatment
Group I: Sequential CommunicationsExperimental Treatment1 Intervention
This sequential arm contains three types of communication to be employed following non-response to the previous type. The initial communication will be a direct message to the patient via the MyPennMedicine. The subsequent message will be sent as a text via the Way To Health app(lication). The final communication will be a nudge to the patient's physician which will send upon opening the patient's chart and will remain as a flag thereafter.
Find a Location
Who is running the clinical trial?
Abramson Cancer Center of the University of PennsylvaniaLead Sponsor
359 Previous Clinical Trials
104,645 Total Patients Enrolled
Abramson Cancer Center at Penn MedicineLead Sponsor
387 Previous Clinical Trials
145,245 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I was diagnosed with serous ovarian cancer over two years ago.My family has a history of breast cancer before age 50.I was diagnosed with breast cancer before turning 50 and it has been over two years.I have undergone genetic counseling or testing before.I was diagnosed with triple negative breast cancer over two years ago.I have a family history of ovarian cancer but am not affected.I have a family history of breast cancer in men but am not affected myself.
Research Study Groups:
This trial has the following groups:- Group 1: Sequential Communications
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are individuals aged 20 and up admissible to this trial?
"This trial exclusively seeks participants aged between 25 to 100 years old. In contrast, there are 62 other clinical trials for younger patients and 798 studies that are recruiting elderly individuals."
Answered by AI
What criteria must potential participants meet in order to take part in this medical research?
"Eligible applicants for this trial must have genetic risk factors, as well as be between 25 and 100 years of age. The team is recruiting a total of 450 participants."
Answered by AI
Are there any available vacancies for participants in this trial?
"According to the information on clinicaltrials.gov, this trial is not presently open for enrollment. Initially posted in February 15th 2023, the last update was made on February 8th 2023. Nevertheless, there are currently 833 other trials that are recruiting participants at this moment."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger